SFC Fluidics
Manufacturing · Arkansas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
534 W Research Center Blvd Ste 260, Faye...Phone Number
(479) 527-6810Website
www.sfc-fluidics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About SFC Fluidics
SFC Fluidics, Inc. specializes in developing next-generation devices aimed at improving diabetes care, including their proprietary Panda Insulin Delivery System. The company addresses the significant healthcare challenge posed by diabetes, which accounts for 10% of global healthcare spending. Their innovative technologies are designed to enhance clinical outcomes while reducing treatment costs. SFC Fluidics is part of the VIC Technology Venture Development ecosystem and is focused on expanding its solutions to other disease states.Explore more
SFC Fluidics Org Chart
AW
Projects Coordinator
AM
Projects Coordinator
HM
Research Engineer
MP
Systems Analyst
CR
Senior Scientist
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SFC Fluidics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if SFC Fluidics had a recent Job posting/layoffs
Product Launch: Get notified when SFC Fluidics launches new products
SFC Fluidics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once SFC Fluidics has new funding data
Check out if SFC Fluidics is spiking on competitors!
Check if SFC Fluidics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on SFC Fluidics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at SFC Fluidics
Recommended Actions
Reach out to Masked Content who joined SFC Fluidics as Masked Content
Find 2 more new buyers
Compare Similar Companies to SFC Fluidics
Compare insights from companies similar to SFC Fluidics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
SFC Fluidics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
SFC Fluidics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about SFC Fluidics.
SFC Fluidics financials insights
Gather financial insights about SFC Fluidics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Private Equity
$1M
2014
Series B
$2M
2015
Unspecified
$175K
2021
Debt
$144K
2025
Private Equity
$250K
SFC Fluidics Tech Stack
A closer look at the technologies used by SFC Fluidics
Most Recent Scoops
Funding
Funding
Funding
Project
Award, Spending/Investment, Workforce Management, Clinical Operations, Healthcare Technology, Operations
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Funding
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SFC Fluidics
Sign Up For FreeTo access detailed company insights
SFC Fluidics, Inc. specializes in developing next-generation devices aimed at improving diabetes care, including their proprietary Panda Insulin Delivery System. The company addresses the significant healthcare challenge posed by diabetes, which accounts for 10% of global healthcare spending. Their innovative technologies are designed to enhance cl... Read More
